Literature DB >> 3876287

Degradation of muramyl dipeptide by mammalian serum.

J Harrison, A Fox.   

Abstract

Muramyl dipeptide, N-acetylmuramyl-L-alanine-D-isoglutamine (MDP), is the minimal biologically active subunit of bacterial peptidoglycan and elicits an acute inflammation in vivo. We now report that MDP is degraded by normal rat serum into its constituents, N-acetylmuramic acid and L-alanine-D- isoglutamine. The dipeptide is further degraded into its components L-alanine and D-isoglutamine. These results may help to explain how inflammation elicited by MDP is terminated in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876287      PMCID: PMC262175          DOI: 10.1128/iai.50.1.320-321.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.

Authors:  L Chedid; C Carelli; F Audibert
Journal:  J Reticuloendothel Soc       Date:  1979-12

2.  Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum.

Authors:  Z Valinger; B Ladesić; J Tomasić
Journal:  Biochim Biophys Acta       Date:  1982-02-04

3.  The metabolic fate of 14C-labeled peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine.

Authors:  J Tomasić; B Ladesić; Z Valinger; I Hrsak
Journal:  Biochim Biophys Acta       Date:  1980-04-17

4.  The metabolic fate of 14C-labeled immunoadjuvant peptidoglycan monomer. II. In vitro studies.

Authors:  B Ladesić; J Tomasić; S Kveder; I Hrsak
Journal:  Biochim Biophys Acta       Date:  1981-11-18

5.  Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.

Authors:  Z Zídek; K Maśek; Z Jiricka
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry.

Authors:  A Fox; J H Schwab; T Cochran
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Muramyl dipeptide-induced adjuvant arthritis.

Authors:  S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments.

Authors:  R K Sinha; R S Rosenthal
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

Authors:  M Parant; F Parant; L Chedid; A Yapo; J F Petit; E Lederer
Journal:  Int J Immunopharmacol       Date:  1979

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  9 in total

1.  Elimination of group A streptococcal cell walls from mammalian tissues.

Authors:  J Gilbart; A Fox
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

2.  Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.

Authors:  E Simelyte; M Rimpiläinen; L Lehtonen; X Zhang; P Toivanen
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids.

Authors:  A Fox; K Fox; B Christensson; D Harrelson; M Krahmer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Systemic injection of group A streptococcal peptidoglycan-polysaccharide complexes elicits persistent neutrophilia and monocytosis associated with polyarthritis in rats.

Authors:  A F Wells; J A Hightower; C Parks; E Kufoy; A Fox
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

5.  Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).

Authors:  Marlyn P Langford; Dequan Chen; Tomas C Welbourne; Thomas B Redens; James P Ganley
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

6.  Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits.

Authors:  A Fox; K Fox
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Strengthening peptide-based drug activity with novel glyconanoparticle.

Authors:  Jordan D Lewicky; Alexandrine L Martel; Nya L Fraleigh; Amanda Boraman; Thi M-D Nguyen; Peter W Schiller; Tze Chieh Shiao; René Roy; Hoang-Thanh Le
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 8.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29

9.  Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening.

Authors:  Samo Guzelj; Tihomir Tomašič; Žiga Jakopin
Journal:  Biomolecules       Date:  2022-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.